Theo Coughlin
Investment Banking Analyst | Chicago, Illinois, United States
Professional Overview
Theo Coughlin is an accomplished Investment Banking Analyst with a proven track record of providing strategic advisory services to clients in the biopharma industry. He leverages his strong financial acumen, industry expertise, and analytical capabilities to deliver high-impact solutions that drive value for his clients.
Experience Summary
Current Role
Theo currently serves as an Investment Banking Analyst at Gordon Dyal & Co. Advisory Group LP, where he is responsible for conducting in-depth financial and market analyses, developing comprehensive valuation models, and supporting the execution of complex transactions, including mergers, acquisitions, and capital raises. He collaborates closely with senior investment bankers to provide clients with tailored strategic advice and seamless transaction support.
Career Progression
Prior to his current role, Theo gained valuable experience as an Investment Banking Analyst at William Blair, where he specialized in the biopharma sector. In this role, he played a key part in advising clients on strategic initiatives, evaluating market trends, and identifying potential growth opportunities. Theo also previously held internships at Waud Capital Partners and Strides Pharma Inc., where he honed his research and analytical skills in the investment management and pharmaceutical industries, respectively.
Academic Background
Theo holds a Bachelor of Science degree in Finance from the University of Illinois at Urbana-Champaign, where he graduated with honors. During his time at the university, he was an active member of the Finance Club and participated in various investment-related case competitions, showcasing his ability to apply his financial knowledge in practical settings.
Areas of Expertise
- Financial modeling and valuation
- Mergers and acquisitions advisory
- Capital markets transactions
- Biopharma industry analysis
- Strategic planning and execution
- Cross-functional collaboration and client management
Professional Impact
Through his work at Gordon Dyal & Co. Advisory Group LP, Theo has contributed to the successful completion of several high-profile transactions, including the $250 million acquisition of a leading biopharmaceutical company and the $150 million Series B funding round for a promising biotech startup. His analytical insights and strategic recommendations have been instrumental in helping clients navigate complex industry challenges and capitalize on emerging opportunities.
Conclusion
With his extensive experience in investment banking, deep industry knowledge, and strong problem-solving skills, Theo Coughlin is well-positioned to continue driving value for his clients and making a meaningful impact within the biopharma sector. His unwavering commitment to excellence and collaborative approach make him a valuable asset to any team.
